Xiuyan Wang
Director - Cell Therapy & Cell Engineering Core Memorial Sloan Kettering Cancer Center
Xiuyan Wang is Director of the BioTherapeutics Core Facility at Memorial Sloan Kettering Cancer Center. She has a demonstrated record of developing and advancing cell therapy for T cells and haematopoietic stem cells from pre-clinical stage to phase I/II clinical trials. She has over 18 years of hands-on cGMP experience supporting 20+ phase I/II clinical trials, with extensive expertise in CMC, FDA and NIH regulations, and large-scale manufacturing of clinical-grade viral vectors and gene-edited cell therapies.
